|Effect of acute betaine administration on hepatic metabolism of S-amino acids in rats and mice.|
|PMID: 12732369 Owner: NLM Status: MEDLINE|
|Alterations of hepatic glutathione level by betaine were observed previously. In this study effects of betaine administration (1000 mg/kg, i.p.) on S-amino acid metabolism in rats and mice were investigated. Hepatic glutathione level decreased rapidly followed by marked elevation in 24 hr. Concentrations of S-adenosylmethionine, S-adenosylhomocysteine, and methionine were increased whereas cystathionine decreased significantly, suggesting that homocysteine generated in the methionine cycle is preferentially remethylated to methionine rather than being utilized for synthesis of cysteine. Hepatic cysteine concentration declined immediately, but plasma cysteine increased. Effect of betaine on hepatic cysteine uptake was estimated from the difference in cysteine concentration in major blood vessels connected to liver. Cysteine concentration either in the portal vein or abdominal aorta was not altered, however, a significant increase was noted in the hepatic vein, indicating that hepatic uptake of cysteine was decreased by betaine treatment. Activities of glutamate cysteine ligase, cystathionine beta-synthase, and cystathionine gamma-lyase were elevated in 24 hr. Pretreatment with propargylglycine, an irreversible inhibitor of cystathionine gamma-lyase, did not abolish the betaine-induced reduction of hepatic glutathione in 4 hr, however, the elevation at t=24 hr was blocked completely. In conclusion the present results indicate that betaine administration induces time-dependent changes on hepatic metabolism of S-amino acids. Betaine enhances metabolic reactions in the methionine cycle, but inhibits cystathionine synthesis and cysteine uptake, leading to a decrease in supply of cysteine for glutathione synthesis. Reduction in glutathione is subsequently reversed due to induction of cysteine synthesis and glutamate cysteine ligase activity.|
|Sang K Kim; Kwon H Choi; Young C Kim|
Related Documents :
|4004239 - Specific uptake rates of amino acids by attached and free-living bacteria in a mesotrop...
11572629 - Body and intestinal growth of broiler chicks on a commercial starter diet. 3. developme...
2320439 - The influence of lactate and dipyridamole on myocardial fatty acid metabolism in man, t...
8828229 - Aspartate transport by the dct system in rhizobium leguminosarum negatively affects nit...
9458279 - Uptake of long chain fatty acids by human placental choriocarcinoma (bewo) cells: role ...
9409709 - Arachidonic acid inhibits uptake of amino acids and potentiates pkc effects on glutamat...
23994369 - 3,4-dihydroxy-5-nitrobenzaldehyde (dhnb) is a potent inhibitor of xanthine oxidase: a p...
22054129 - Expanding the catalytic repertoire of dnazymes by modified nucleosides.
6869549 - Intraduodenal emulsions of oleic acid augment acid-induced canine pancreatic secretion.
|Type: Journal Article; Research Support, Non-U.S. Gov't|
|Title: Biochemical pharmacology Volume: 65 ISSN: 0006-2952 ISO Abbreviation: Biochem. Pharmacol. Publication Date: 2003 May|
|Created Date: 2003-05-06 Completed Date: 2003-06-16 Revised Date: 2006-11-15|
Medline Journal Info:
|Nlm Unique ID: 0101032 Medline TA: Biochem Pharmacol Country: England|
|Languages: eng Pagination: 1565-74 Citation Subset: IM|
|College of Pharmacy, Seoul National University, San 56-1 Shinrim-Dong, Kwanak-Ku, Seoul, South Korea.|
|APA/MLA Format Download EndNote Download BibTex|
Amino Acids / metabolism
Betaine / administration & dosage*, pharmacology
Biological Transport / drug effects
Cystathionine / metabolism
Cystathionine gamma-Lyase / metabolism
Enzyme Inhibitors / pharmacology
Glutamate-Cysteine Ligase / metabolism
Glutathione / metabolism
Glycine / analogs & derivatives*, pharmacology
Liver / drug effects*, metabolism
Methionine / metabolism
Mice, Inbred ICR
Oxygenases / metabolism
S-Adenosylhomocysteine / metabolism
S-Adenosylmethionine / metabolism*
Taurine / metabolism
gamma-Glutamyltransferase / metabolism
|0/Alkynes; 0/Amino Acids; 0/Enzyme Inhibitors; 107-35-7/Taurine; 107-43-7/Betaine; 29908-03-0/S-Adenosylmethionine; 56-40-6/Glycine; 56-88-2/Cystathionine; 63-68-3/Methionine; 64165-64-6/propargylglycine; 70-18-8/Glutathione; 979-92-0/S-Adenosylhomocysteine; EC 1.13.-/Oxygenases; EC 1.13.11.-/Dioxygenases; EC 188.8.131.52/Cysteine Dioxygenase; EC 184.108.40.206/gamma-Glutamyltransferase; EC 220.127.116.11/Cystathionine gamma-Lyase; EC 18.104.22.168/Glutamate-Cysteine Ligase|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effect of sesquiterpene lactones on the expression of the activation marker CD69 and of IL-2 in T-ly...
Next Document: Cognitive therapy versus applied relaxation as treatment of generalized anxiety disorder.